Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 3/2013

01.12.2013

Femoral vein thrombosis after right-sided electrophysiological procedures

verfasst von: Ghassan Moubarak, Stéphanie Bonhomme, Géraldine Vedrenne, Claire Bouleti, Jacky Ollitrault, Pascal Priollet, Romain Cador, Serge Cazeau

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Electrophysiological studies and radiofrequency catheter ablations require single or multiple sheath placements through femoral vein cannulation. The objective of this study was to determine the incidence, predictors, and outcomes of deep vein thrombosis (DVT) following such procedures.

Methods and results

We prospectively enrolled 220 consecutive patients with a median age of 70 [60–79] years. The median duration of the procedures from insertion to removal of sheaths was 45 [30–75] min. At least two sheaths were inserted in 158 (72 %) of the cases. Duplex ultrasonography evaluation of the lower leg veins was performed 6 h after the procedure and revealed common femoral vein thrombosis in 11 (5 %) patients. All thrombi were partial and none was complete. Thrombi were mobile in four patients and extended to the external iliac vein in three patients. None of the patients presented with clinical signs of DVT or pulmonary embolism. Anticoagulation was prescribed for 2–4 weeks and a follow-up duplex ultrasonography obtained in the first seven patients revealed complete resolution of thrombi in all cases. On multivariate analysis, two predictors of thrombosis occurrence were identified: a greater sum of sheath diameters (odds ratio, 1.41 [95 % confidence interval, 1.25–1.60] per 1-French increase; p < 0.001) and a longer procedural duration (odds ratio, 1.02 [95 % confidence interval, 1.00–1.04] per 1-min increase; p = 0.04).

Conclusions

Asymptomatic femoral DVT occur in 5 % of electrophysiological studies and right-heart radiofrequency catheter ablations, particularly when large sheaths are inserted for a longer period. The role of anticoagulation in this clinical setting warrants further evaluation.
Literatur
1.
Zurück zum Zitat Cappato, R., Calkins, H., Chen, S. A., et al. (2010). Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. Arrhythmia and Electrophysiology, 3(1), 32–38.PubMedCrossRef Cappato, R., Calkins, H., Chen, S. A., et al. (2010). Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. Arrhythmia and Electrophysiology, 3(1), 32–38.PubMedCrossRef
2.
Zurück zum Zitat Oral, H., Chugh, A., Ozaydin, M., et al. (2006). Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation, 114(8), 759–765.PubMedCrossRef Oral, H., Chugh, A., Ozaydin, M., et al. (2006). Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation, 114(8), 759–765.PubMedCrossRef
3.
Zurück zum Zitat Calkins, H., Kuck, K. H., Cappato, R., et al. (2012). 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Journal of Interventional Cardiac Electrophysiology, 33(2), 171–257.PubMedCrossRef Calkins, H., Kuck, K. H., Cappato, R., et al. (2012). 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Journal of Interventional Cardiac Electrophysiology, 33(2), 171–257.PubMedCrossRef
4.
Zurück zum Zitat Davutoglu, V., Kervancioglu, S., Dinckal, H., et al. (2004). High incidence of occult femoral vein thrombosis related to multiple venous sheaths during electrophysiological studies. Heart, 90(9), 1061–1062.PubMedCrossRef Davutoglu, V., Kervancioglu, S., Dinckal, H., et al. (2004). High incidence of occult femoral vein thrombosis related to multiple venous sheaths during electrophysiological studies. Heart, 90(9), 1061–1062.PubMedCrossRef
5.
Zurück zum Zitat Chen, J. Y., Chang, K. C., Lin, Y. C., Chou, H. T., & Hung, J. S. (2004). Safety and outcomes of short-term multiple femoral venous sheath placement in cardiac electrophysiological study and radiofrequency catheter ablation. Japanese Heart Journal, 45(2), 257–264.PubMedCrossRef Chen, J. Y., Chang, K. C., Lin, Y. C., Chou, H. T., & Hung, J. S. (2004). Safety and outcomes of short-term multiple femoral venous sheath placement in cardiac electrophysiological study and radiofrequency catheter ablation. Japanese Heart Journal, 45(2), 257–264.PubMedCrossRef
6.
Zurück zum Zitat Alizadeh, A., Yazdi, A. H., Kafi, M., Rad, M. A., Moradi, M., & Emkanjoo, Z. (2012). Predictors of local venous complications resulting from electrophysiological procedures. Cardiology Journal, 19(1), 15–19.PubMedCrossRef Alizadeh, A., Yazdi, A. H., Kafi, M., Rad, M. A., Moradi, M., & Emkanjoo, Z. (2012). Predictors of local venous complications resulting from electrophysiological procedures. Cardiology Journal, 19(1), 15–19.PubMedCrossRef
7.
Zurück zum Zitat Lee, D. S., Dorian, P., Downar, E., et al. (2001). Thrombogenicity of radiofrequency ablation procedures: what factors influence thrombin generation? Europace, 3(3), 195–200.PubMedCrossRef Lee, D. S., Dorian, P., Downar, E., et al. (2001). Thrombogenicity of radiofrequency ablation procedures: what factors influence thrombin generation? Europace, 3(3), 195–200.PubMedCrossRef
8.
Zurück zum Zitat Goldhaber, S. Z., & Bounameaux, H. (2012). Pulmonary embolism and deep vein thrombosis. Lancet, 379(9828), 1835–1846.PubMedCrossRef Goldhaber, S. Z., & Bounameaux, H. (2012). Pulmonary embolism and deep vein thrombosis. Lancet, 379(9828), 1835–1846.PubMedCrossRef
9.
Zurück zum Zitat Hindricks, G. (1993). The Multicentre European Radiofrequency Survey (MERFS): complications of radiofrequency catheter ablation of arrhythmias. The Multicentre European Radiofrequency Survey (MERFS) investigators of the Working Group on Arrhythmias of the European Society of Cardiology. European Heart Journal, 14(12), 1644–1653.PubMedCrossRef Hindricks, G. (1993). The Multicentre European Radiofrequency Survey (MERFS): complications of radiofrequency catheter ablation of arrhythmias. The Multicentre European Radiofrequency Survey (MERFS) investigators of the Working Group on Arrhythmias of the European Society of Cardiology. European Heart Journal, 14(12), 1644–1653.PubMedCrossRef
Metadaten
Titel
Femoral vein thrombosis after right-sided electrophysiological procedures
verfasst von
Ghassan Moubarak
Stéphanie Bonhomme
Géraldine Vedrenne
Claire Bouleti
Jacky Ollitrault
Pascal Priollet
Romain Cador
Serge Cazeau
Publikationsdatum
01.12.2013
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 3/2013
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-013-9832-4

Weitere Artikel der Ausgabe 3/2013

Journal of Interventional Cardiac Electrophysiology 3/2013 Zur Ausgabe

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.